Kaplan–Meier analysis revealed that seven of these markers significantly correlated with the OS rates of patients with CRC, and five of them could be considered “protective” genes, whereas CDKN2A and LIPT1 could be considered “risk” genes. Here, CDKN2A is linked to colorectal carcinoma.